Joint Development of Novel Synthetic Peptide Based Growth Factor with Orizuru Therapeutics Inc.
2023/08/22
TOKYO and KANAGAWA, JAPAN – August 22nd, 2023 - PeptiGrowth Inc (PeptiGrowth), a Japanese biotechnology company focusing on the development of synthetic peptide based growth factors and Orizuru Therapeutics, Inc(OZTx), a Japanese biopharmaceutical company focusing on the research and development of iPSC-derived regenerative medicine have entered into a joint development agreement to create a novel synthetic peptide that will replace a recombinant growth factor used in the manufacturing of regenerative medicine product developed by OZTx.
